Text this: Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 _    _     _____    _    _    _    _             
| \  / ||  |  ___|| | \  / || | || | ||   ____    
|  \/  ||  | ||__   |  \/  || | || | ||  |    \\  
| .  . ||  | ||__   | .  . || | \\_/ ||  | [] ||  
|_|\/|_||  |_____|| |_|\/|_||  \____//   |  __//  
`-`  `-`   `-----`  `-`  `-`    `---`    |_|`-`   
                                         `-`